Cargando…

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens

In patients with muscle invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) prior to radical cystectomy has improved survival but there is an urgent unmet need to identify prognostic and predictive biomarkers to stratify patients who will benefit from treatment. This study aimed to examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahlin, Sara, Nodin, Björn, Leandersson, Karin, Boman, Karolina, Jirström, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791444/ https://www.ncbi.nlm.nih.gov/pubmed/31646091 http://dx.doi.org/10.1080/2162402X.2019.1644108

Ejemplares similares

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
por: Berntsson, Jonna, et al.
Publicado: (2018)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
por: Svensson, Maria C., et al.
Publicado: (2019)

T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival
por: Christina Svensson, Maria, et al.
Publicado: (2021)

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
por: Wahlin, Sara, et al.
Publicado: (2022)

Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer
por: Andersson, Nina, et al.
Publicado: (2020)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

T1 bladder cancer on restaging transurethral resection should be treated with immediate cystectomy
por: Gautam, Gagan, et al.
Publicado: (2007)

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
por: Berntsson, Jonna, et al.
Publicado: (2019)

Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study
por: Hau, Sofie Olsson, et al.
Publicado: (2020)

Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens?
por: Mantica, Guglielmo, et al.
Publicado: (2021)

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
por: Wennersten, Christoffer, et al.
Publicado: (2014)

Combination of en bloc transurethral resection with laparoscopic partial cystectomy for paraganglioma of the bladder
por: Urabe, Fumihiko, et al.
Publicado: (2019)

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)

Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies
por: Compérat, Eva, et al.
Publicado: (2021)

The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy
por: La Croce, Giovanni, et al.
Publicado: (2022)

The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
por: Lundgren, Sebastian, et al.
Publicado: (2017)

Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
por: Lundgren, Sebastian, et al.
Publicado: (2020)

Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy
por: Ge, Peng, et al.
Publicado: (2015)

Positive ureteric margins at radical cystectomy: Can it be predicted at initial transurethral resection of bladder tumour?
por: Singh, Onkar, et al.
Publicado: (2018)

Editorial Comment to Combination of en bloc transurethral resection with laparoscopic partial cystectomy for paraganglioma of the bladder
por: Hashimoto, Takeshi
Publicado: (2019)

Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer—Comparison of Transurethral Resection and Radical Cystectomy
por: Yoneda, Kei, et al.
Publicado: (2021)

Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
por: Jeremiasen, Martin, et al.
Publicado: (2020)

Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
por: Petersson, Alexandra, et al.
Publicado: (2022)

The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
por: Svensson, Maria C., et al.
Publicado: (2017)

High Infiltration of CD68(+)/CD163(−) Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
por: Svensson, Maria C., et al.
Publicado: (2022)

The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Necrotic mass after transurethral resection of a bladder tumor: novel management with robotic partial cystectomy
por: Mufarrij, Patrick W., et al.
Publicado: (2007)

Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
por: Berntsson, Jonna, et al.
Publicado: (2017)

AB066. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy
por: Ge, Peng, et al.
Publicado: (2016)

Clinical Efficacy and Quality of Life Assessment of Partial Cystectomy and Plasmakinetic Transurethral Resection of Tumor in Bladder Cancer Patients
por: Li, Zhi-Jia, et al.
Publicado: (2022)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy
por: Pichler, Renate, et al.
Publicado: (2017)

Survival Outcome of Partial Cystectomy versus Transurethral Bladder Tumor Resection in T1 High-Grade Bladder Cancer Patients: A Propensity Score Matching Study
por: Ping, Zheng, et al.
Publicado: (2022)

Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2018)

SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2014)

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5tm0rdm0o8s2ntpbnpmhp5lfrm